Trial intelligence / Profile preview

Deep Inhalation Effect on Mannitol and Methacholine Responsiveness

NCT03505489Phase 3Completed

Sponsor
University of Saskatchewan
Start
Jun 2018
Primary completion
Apr 2019
Modality
Inhalation Devices, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Bronchitol in asthma, sponsored by University of Saskatchewan. Started Jun 2018; status: completed.

02

Drugs

Bronchitol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT03505489.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03505489.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call